Related Experiment Video
Updated: Aug 11, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease
Thierry Charron1, Nafiseh Nili, Bradley H Strauss
1Roy and Ann Foss International Cardiology Research Program, Terrence Donnelly Heart Centre, St Micheal's Hospital, University of Toronto, Ontario.
Insights
In-stent restenosis after percutaneous coronary intervention involves vascular smooth muscle cell proliferation regulated by the cell cycle. This review explores cell cycle regulation and novel therapeutic targets for preventing restenosis.
Area of Science:
- Cardiovascular Medicine
- Cell Biology
- Pharmacology
Background:
- Percutaneous coronary intervention (PCI) is a primary treatment for coronary artery disease.
- In-stent restenosis (ISR), caused by neointimal hyperplasia, limits PCI success.
- Vascular smooth muscle cell (VSMC) proliferation drives ISR, mediated by growth factors and cytokines.
Purpose of the Study:
- To review current understanding of cell cycle regulation in VSMC proliferation.
- To discuss emerging therapeutic strategies targeting the cell cycle for ISR prevention.
Main Methods:
- Literature review of studies on cell cycle regulation and ISR.
- Analysis of growth factor and cytokine signaling pathways involved in VSMC proliferation.
- Identification of potential therapeutic targets within the cell cycle.
Main Results:
- The cell cycle is a critical pathway for VSMC proliferation in ISR.
- Dysregulation of cell cycle checkpoints contributes to excessive neointimal hyperplasia.
- Targeting specific cell cycle regulators shows promise for novel ISR therapies.
Conclusions:
- Understanding cell cycle control is crucial for developing effective ISR treatments.
- Therapeutic strategies aimed at cell cycle modulation offer a promising avenue for improving PCI outcomes.
- Further research into cell cycle-specific therapies is warranted to combat in-stent restenosis.
Abstract:
Percutaneous coronary intervention is the preferred revascularization approach for most patients with coronary artery disease. However, this strategy is limited by renarrowing of the vessel by neointimal hyperplasia within the stent lumen (in-stent restenosis). Vascular smooth muscle cell proliferation is a major component in this healing process. This process is mediated by multiple cytokines and growth factors, which share a common pathway in inducing cell proliferation: the cell cycle. The cell cycle is highly regulated by numerous mechanisms ensuring orderly and coordinated cell division. The present review discusses current concepts related to regulation of the cell cycle and new therapeutic options that target aspects of the cell cycle.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

